Skip to content
Home/Companies/TMT/SynOx Therapeutics
SynOx Therapeutics

SynOx Therapeutics

TMT·Exited 2023
Entry
–
Hold
–
Exit
2023

Who owns SynOx Therapeutics?

SynOx Therapeutics was owned by Gimv.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

SectorTMT
Websitesynoxtherapeutics.com
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2023

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
AgroBiothers
Active
TMTBelgium
Almaviva
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

2Checkout (Avangate)
Exited
Francisco PartnersUS
3Bee
3Bee
Active
AgFunderUS
58 Com
58 Com
Active
Warburg PincusFrance
58.com
Active
General AtlanticChina
8x8
Exited 2024
Francisco PartnersUS
A+ Network
Active
Summit PartnersUS
Track SynOx Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on SynOx Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue